Phase II Study of a Short Course of Weekly High-dose Cisplatin Combined with Long-term Oral Etoposide in Metastatic Malignant Melanoma

By Planting A.S.T.   van der Burg M.E.L.   Goey S.H.   Schellens J.H.M.   Vecht C.   de Boer-Dennert M.   Stoter G.   Verweij J.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 2026-2028

Elsevier

Access to resources Recommend Favorite

Phase II Study of 21 Day Schedule Oral Etoposide in Children

By the New Agents Group of the United Kingdom Children's Cancer Study Group UKCCSG   Davidson A.   Gowing R.   Lowis S.   Newell D.   Lewis I.   Dicks-Mireaux C.   Pinkerton C.R.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1816-1822

Elsevier

Access to resources Recommend Favorite

A Phase I Trial of Prolonged Oral Etoposide and Liposomal Doxorubicin in Ovarian, Peritoneal, and Tubal Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G.   Rodriguez M.   Walker J.   Greer B.   Fusco N.   McGuire W.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 136-139

Elsevier

Access to resources Recommend Favorite

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

By Christodoulou Christos   Bafaloukos Dimitrios   Linardou Helen   Aravantinos Gerassimos   Bamias Aristotelis   Carina Maria   Klouvas George   Skarlos Dimosthenis  

Journal of Neuro-Oncology, Vol. 71, Iss. 1, 2005-01 ,pp. : 61-65

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors

By Lockhart A.   Bukowski R.   Rothenberg M.   Wang K.   Cooper W.   Grover J.   Appleman L.   Mayer P.   Shapiro M.   Zhu A.  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 203-209

Springer Publishing Company

Access to resources Recommend Favorite